Drugs to get cheaper from September in China

Chinese patients are expected to be able to buy 14 kinds of cancer drugs at a lower price from September, according to China's state medical insurance administration.

The drugs are all crucial in dealing with hematological neoplasms and solid tumors, and have great clinical value and huge benefits for patients, the National Healthcare Security Administration said.

It asked pharmaceutical companies to adhere to the price cut in line with the lowered procurement prices of these drugs, Xinhua news agency reported.

A range of several more drugs has been selected to be included in the medical insurance reimbursement list later.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)